We serve DL-Tryptophan CAS:54-12-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
DL-Tryptophan
CAS RN: 54-12-6
Solubility in water | Colorless & clear (c=1) |
Loss on drying | Not more than 0.3% |
Residue on ignition (as sulfate) | Not more than 0.1% |
Chloride (Cl) | Not more than 0.02% |
Sulfate (SO4) | Not more than 0.03% |
Heavy metals (as Pb) | Not more than 20ppm |
Iron (Fe) | Not more than 20ppm |
Ammonium (NH4) | Not more than 0.02% |
Arsenic (As2O3) | Not more than 1ppm |
Other amino acids | Not detected by T.L.C.(The spotted amount, 10μg) |
Assay | 98.5%~101.0% |
Contact us for information like DL-Tryptophan chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(±)-2-Amino-3-(3-indolyl)propionic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(±)-α-Amino-3-indolepropionic acid Use and application,DL-3β-Indolylalanine technical grade,usp/ep/jp grade.
Related News: With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.(S)-Methyl 2-(3-(3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)-3-hydroxypropyl)benzoate manufacturer The man recently traveled to Wuhan, China, and sought medical care soon after his return to Massachusetts.(3R,4R)-3,4-Dimethyl-4-(3-Hydroxyphenyl)Piperidine supplier The man recently traveled to Wuhan, China, and sought medical care soon after his return to Massachusetts.(E)-3-(5-nitrocyclohexen-1-yl)prop-2-enoic acid vendor But several border points remain open, and many medical workers fear that Hong Kong’s well-regarded health care system will be overwhelmed.Further research on Oligomannate’s pharmacological mechanism and long-term safety and effectiveness is required, according to the NMPA statement.